HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

GPI 15427

a PARP-1 inhibitor; no further info available 7/2005
Also Known As:
GPI-15427; GPI15427
Networked: 7 relevant articles (4 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Xu, Weizheng: 6 articles (03/2010 - 11/2003)
2. Zhang, Jie: 6 articles (03/2010 - 11/2003)
3. Scarsella, Marco: 3 articles (08/2006 - 11/2003)
4. Tentori, Lucio: 3 articles (08/2006 - 11/2003)
5. Leonetti, Carlo: 3 articles (08/2006 - 11/2003)
6. Vergati, Matteo: 3 articles (08/2006 - 11/2003)
7. Graziani, Grazia: 3 articles (08/2006 - 11/2003)
8. Cuzzocrea, Salvatore: 2 articles (08/2006 - 12/2005)
9. Lapidus, Rena: 2 articles (08/2006 - 02/2005)
10. Mazzon, Emanuela: 2 articles (08/2006 - 12/2005)

Related Diseases

1. Neoplasms (Cancer)
2. Lymphoma (Lymphomas)
3. Melanoma (Melanoma, Malignant)
4. Glioblastoma (Glioblastoma Multiforme)
5. Colonic Neoplasms (Colon Cancer)

Related Drugs and Biologics

1. Asp(5)- oxytocin (OXA)
2. Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
3. temozolomide (Temodar)
4. irinotecan (Camptosar)
5. 2- (4- methyl- piperazin- 1- yl)- 5H- benzo(c)(1,5)naphthyridin- 6- one
6. Streptozocin (Streptozotocin)
7. Poly Adenosine Diphosphate Ribose
8. Mesylates (Mesylate)
9. Formaldehyde (Formol)
10. Adenosine Diphosphate Ribose (ADP-Ribose)

Related Therapies and Procedures

1. Intravenous Injections
2. Heterologous Transplantation (Xenotransplantation)
3. Oral Administration